HC quashes Centre’s ban on oxytocin drug production, sale

Delhi | Friday | 14th December, 2018

Summary:

New Delhi: The Delhi High Court on Friday set aside a Central Government order restraining private companies from manufacturing and selling oxytocin drug. The court also observed that oxytocin was an essential life saving drug. The State-run Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL) was solely allowed to produce the drug for domestic use. Earlier this year, the government had restricted the manufacture of oxytocin formulations for domestic use to public sector only. Chawla observed that the order was “unreasonable and arbitrary” and did not seem to be based on any scientific study..